Qualitative study on decision-making by prostate cancer physicians during active surveillance

被引:25
|
作者
Loeb, Stacy [1 ,2 ,3 ,4 ]
Curnyn, Caitlin [2 ]
Fagerlin, Angela [5 ,6 ]
Braithwaite, Ronald Scott [2 ]
Schwartz, Mark D. [2 ,4 ]
Lepor, Herbert [1 ,3 ]
Carter, Herbert Ballentine [7 ]
Sedlander, Erica [2 ]
机构
[1] NYU, Dept Urol, New York, NY USA
[2] NYU, Dept Populat Hlth, New York, NY USA
[3] NYU, Laura & Isaac Perlmutter Canc Ctr, New York, NY USA
[4] Manhattan Vet Affairs Med Ctr, New York, NY USA
[5] Univ Utah, Dept Populat Hlth Sci, Salt Lake City, UT USA
[6] Informat Decis Enhancement & Surveillance IDEAS C, Salt Lake City, UT USA
[7] Johns Hopkins Univ Hosp, Brady Urol Inst, Baltimore, MD 21287 USA
关键词
prostate cancer; active surveillance; markers; qualitative; survey; MANAGEMENT; MEN; GUIDELINE;
D O I
10.1111/bju.13651
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
Objective To explore and identify factors that influence physicians' decisions while monitoring patients with prostate cancer on active surveillance (AS). Subjects and Methods A purposive sampling strategy was used to identify physicians treating prostate cancer from diverse clinical backgrounds and geographic areas across the USA. We conducted 24 in-depth interviews from July to December 2015, until thematic saturation was reached. The Applied Thematic Analysis framework was used to guide data collection and analysis. Interview transcripts were reviewed and coded independently by two researchers. Matrix analysis and NVIVO software were used for organization and further analysis. Results Eight key themes emerged to explain variation in AS monitoring: (i) physician comfort with AS; (ii) protocol selection; (iii) beliefs about the utility and quality of testing; (iv) years of experience and exposure to AS during training; (v) concerns about inflicting 'harm'; (vi) patient characteristics; (vii) patient preferences; and (viii) financial incentives. Conclusion These qualitative data reveal which factors influence physicians who manage patients on AS. There is tension between providing standardized care while also considering individual patients' needs and health status. Additional education on AS is needed during urology training and continuing medical education. Future research is needed to empirically understand whether any specific protocol is superior to tailored, individualized care.
引用
收藏
页码:32 / 39
页数:8
相关论文
共 50 条
  • [21] Active Surveillance for Prostate Cancer: Overview and Update
    Klotz, Laurence
    CURRENT TREATMENT OPTIONS IN ONCOLOGY, 2013, 14 (01) : 97 - 108
  • [22] Prostate Cancer and the Increasing Role of Active Surveillance
    Alonzo, David Gabriel
    Mure, Amanda Lynne
    Soloway, Mark S.
    POSTGRADUATE MEDICINE, 2013, 125 (05) : 109 - 116
  • [23] Communicating risk in active surveillance of localised prostate cancer: a protocol for a qualitative study
    Rapport, Frances
    Hogden, Anne
    Gurney, Howard
    Gillatt, David
    Bierbaum, Mia
    Shih, Patti
    Churruca, Kate
    BMJ OPEN, 2017, 7 (10):
  • [24] Active surveillance for prostate cancer: an Australian experience
    Ischia, Joseph J.
    Pang, Chia Y.
    Tay, Yeng K.
    Christopher, F. D.
    Suen, Li Wai
    Aw, Hau C.
    Frydenberg, Mark
    BJU INTERNATIONAL, 2012, 109 : 40 - 43
  • [25] Active surveillance protocol in prostate cancer in Portugal
    Gaspar, S. R. da Silva
    Fernandes, M.
    Castro, A.
    Oliveira, T.
    Dias, J. Santos
    dos Reis, J. Palma
    ACTAS UROLOGICAS ESPANOLAS, 2022, 46 (06): : 329 - 339
  • [26] Can systemic immune-inflammation index and hematologic parameters aid in decision-making for active surveillance or curative treatment in low-risk prostate cancer?
    Baylan, Burhan
    Ulusoy, Kemal
    Ekenci, Berk
    Kartal, Ibrahim Guven
    ASIAN JOURNAL OF SURGERY, 2024, 47 (03) : 1360 - 1365
  • [27] Impact of a decision aid on newly diagnosed prostate cancer patients' understanding of the rationale for active surveillance
    Formica, Margaret K.
    Wason, Shaun
    Seigne, John D.
    Stewart, Telisa M.
    PATIENT EDUCATION AND COUNSELING, 2017, 100 (05) : 812 - 817
  • [28] Multi-level Factors to Build Confidence and Support in Active Surveillance for Low-Risk Prostate Cancer: A Qualitative Study
    Chen, Jason C.
    Subramanian, Lalita
    Skolarus, Ted A.
    Hawley, Sarah T.
    Rankin, Aaron
    Fetters, Michael D.
    Witzke, Karla
    Borza, Tudor
    Radhakrishnan, Archana
    JOURNAL OF GENERAL INTERNAL MEDICINE, 2025, : 1107 - 1115
  • [29] Anxiety and Distress During Active Surveillance for Early Prostate Cancer
    van den Bergh, Roderick C. N.
    Essink-Bot, Marie-Louise
    Roobol, Monique J.
    Wolters, Tineke
    Schroder, Fritz H.
    Bangma, Chris H.
    Steyerberg, Ewout W.
    CANCER, 2009, 115 (17) : 3868 - 3878
  • [30] Indications for intervention during active surveillance of prostate cancer: a comparison of the Johns Hopkins and Prostate Cancer Research International Active Surveillance (PRIAS) protocols
    Kates, Max
    Tosoian, Jeffrey J.
    Trock, Bruce J.
    Feng, Zhaoyong
    Carter, H. Ballentine
    Partin, Alan W.
    BJU INTERNATIONAL, 2015, 115 (02) : 216 - 222